FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384822416> ?p ?o ?g. }

• W4384822416 endingPage "1252" @default.
• W4384822416 startingPage "1252" @default.
• W4384822416 abstract "The longitudinal response to the COVID-19 vaccines among patients on hemodialysis with and without prior SARS-CoV-2 infection has not been well characterized.To guide vaccination strategies in patients on hemodialysis, it is critical to characterize the longevity and efficacy of the vaccine; therefore, we conducted a prospective single-center monthly antibody surveillance study between March 2021 and March 2022 to investigate the dynamic humoral response to a series of COVID-19 mRNA vaccines in patients on hemodialysis with and without prior SARS-CoV-2 infection. Monthly quantitative antibody testing was performed using the Beckman Coulter Access SARS-CoV-2 IgG Antibody Test©, which detects IgG antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein.This cohort of 30 participants (mean age: 61 ± 3 years) predominantly self-identified as African American (97%) and male (53%). Eight participants (27%) had recovered from COVID-19 (recovered) before the vaccine initiation. All participants received two vaccine doses, and 86.6% received a 6-month booster dose. Among patients naïve to COVID-19, the antibody positivity rate (APR) was 55% post-first-dose, 91% post-second-dose, 50% pre-booster at 6 months, 100% post-booster, and 89% at 6 months post-booster. Recovered patients sustained a consistent 100% APR throughout the year. The naïve patients demonstrated lower peak antibody levels post-second-dose than the recovered patients (17.9 ± 3.2 vs. 44.7 ± 5.6, p < 0.001). The peak antibody levels post-booster showed no significant difference between both groups (27.1 ± 3.9 vs. 37.9 ± 8.2, p = 0.20). Two naïve patients contracted COVID-19 during the follow-up period.The patients naïve to COVID-19 exhibited an attenuated and foreshortened antibody response following two doses of the mRNA vaccines compared with the recovered patients, who maintained 100% APR before the booster dose. The 6-month booster dose counteracted declining immunity and stimulated antibody responses in the naïve patients, even in previously non-responsive patients. This observation implies that different booster vaccination strategies might be required for COVID-19-naïve and -recovered patients. Post-vaccination antibody testing may serve as a valuable tool for guiding vaccination strategies." @default.
• W4384822416 created "2023-07-21" @default.
• W4384822416 creator A5005993471 @default.
• W4384822416 creator A5012780468 @default.
• W4384822416 creator A5013078425 @default.
• W4384822416 creator A5054209430 @default.
• W4384822416 creator A5054475946 @default.
• W4384822416 creator A5067550430 @default.
• W4384822416 creator A5074783469 @default.
• W4384822416 creator A5076326299 @default.
• W4384822416 creator A5078310357 @default.
• W4384822416 creator A5078874316 @default.
• W4384822416 creator A5080217422 @default.
• W4384822416 creator A5088833276 @default.
• W4384822416 creator A5090055742 @default.
• W4384822416 date "2023-07-18" @default.
• W4384822416 modified "2023-09-27" @default.
• W4384822416 title "COVID-19 Vaccine Antibody Response in a Single-Center Urban Hemodialysis Unit" @default.
• W4384822416 cites W2994878984 @default.
• W4384822416 cites W3046356037 @default.
• W4384822416 cites W3047144258 @default.
• W4384822416 cites W3080075429 @default.
• W4384822416 cites W3087816957 @default.
• W4384822416 cites W3095404113 @default.
• W4384822416 cites W3130921989 @default.
• W4384822416 cites W3153214707 @default.
• W4384822416 cites W3154963136 @default.
• W4384822416 cites W3167220489 @default.
• W4384822416 cites W3174017401 @default.
• W4384822416 cites W3174622419 @default.
• W4384822416 cites W3177852708 @default.
• W4384822416 cites W3184481055 @default.
• W4384822416 cites W3186535828 @default.
• W4384822416 cites W3188358906 @default.
• W4384822416 cites W3193394413 @default.
• W4384822416 cites W3202792757 @default.
• W4384822416 cites W3204661328 @default.
• W4384822416 cites W3211936650 @default.
• W4384822416 cites W3212047549 @default.
• W4384822416 cites W3216033847 @default.
• W4384822416 cites W4200172978 @default.
• W4384822416 cites W4212835565 @default.
• W4384822416 cites W4212956138 @default.
• W4384822416 cites W4220929994 @default.
• W4384822416 cites W4229050648 @default.
• W4384822416 cites W4283713632 @default.
• W4384822416 cites W4300862453 @default.
• W4384822416 doi "https://doi.org/10.3390/vaccines11071252" @default.
• W4384822416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37515067" @default.
• W4384822416 hasPublicationYear "2023" @default.
• W4384822416 type Work @default.
• W4384822416 citedByCount "0" @default.
• W4384822416 crossrefType "journal-article" @default.
• W4384822416 hasAuthorship W4384822416A5005993471 @default.
• W4384822416 hasAuthorship W4384822416A5012780468 @default.
• W4384822416 hasAuthorship W4384822416A5013078425 @default.
• W4384822416 hasAuthorship W4384822416A5054209430 @default.
• W4384822416 hasAuthorship W4384822416A5054475946 @default.
• W4384822416 hasAuthorship W4384822416A5067550430 @default.
• W4384822416 hasAuthorship W4384822416A5074783469 @default.
• W4384822416 hasAuthorship W4384822416A5076326299 @default.
• W4384822416 hasAuthorship W4384822416A5078310357 @default.
• W4384822416 hasAuthorship W4384822416A5078874316 @default.
• W4384822416 hasAuthorship W4384822416A5080217422 @default.
• W4384822416 hasAuthorship W4384822416A5088833276 @default.
• W4384822416 hasAuthorship W4384822416A5090055742 @default.
• W4384822416 hasBestOaLocation W43848224161 @default.
• W4384822416 hasConcept C121332964 @default.
• W4384822416 hasConcept C12590561 @default.
• W4384822416 hasConcept C126322002 @default.
• W4384822416 hasConcept C1276947 @default.
• W4384822416 hasConcept C159654299 @default.
• W4384822416 hasConcept C188816634 @default.
• W4384822416 hasConcept C203014093 @default.
• W4384822416 hasConcept C203165030 @default.
• W4384822416 hasConcept C22070199 @default.
• W4384822416 hasConcept C2778063415 @default.
• W4384822416 hasConcept C2779134260 @default.
• W4384822416 hasConcept C2780073493 @default.
• W4384822416 hasConcept C3008058167 @default.
• W4384822416 hasConcept C32611913 @default.
• W4384822416 hasConcept C524204448 @default.
• W4384822416 hasConcept C71924100 @default.
• W4384822416 hasConcept C72563966 @default.
• W4384822416 hasConceptScore W4384822416C121332964 @default.
• W4384822416 hasConceptScore W4384822416C12590561 @default.
• W4384822416 hasConceptScore W4384822416C126322002 @default.
• W4384822416 hasConceptScore W4384822416C1276947 @default.
• W4384822416 hasConceptScore W4384822416C159654299 @default.
• W4384822416 hasConceptScore W4384822416C188816634 @default.
• W4384822416 hasConceptScore W4384822416C203014093 @default.
• W4384822416 hasConceptScore W4384822416C203165030 @default.
• W4384822416 hasConceptScore W4384822416C22070199 @default.
• W4384822416 hasConceptScore W4384822416C2778063415 @default.
• W4384822416 hasConceptScore W4384822416C2779134260 @default.
• W4384822416 hasConceptScore W4384822416C2780073493 @default.
• W4384822416 hasConceptScore W4384822416C3008058167 @default.
• W4384822416 hasConceptScore W4384822416C32611913 @default.

• next